EW
GILD icon

Evoke Wealth’s Gilead Sciences GILD Stock Holding History

Evoke Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$406K Sell
2,909
-1,111
-28% -$156K 0.01% 462
2025
Q4 		$493K Buy
4,020
+459
+13% +$55.8K 0.01% 393
2025
Q3 		$395K Buy
3,561
+170
+5% +$19.3K 0.01% 427
2025
Q2 		$376K Buy
+3,391
New +$361K 0.01% 404
2022
Q4 		– Sell
-1,197
Closed -$74K – 681
2022
Q3 		$74K Buy
1,197
+31
+3% +$1.96K ﹤0.01% 461
2022
Q2 		$72K Sell
1,166
-317
-21% -$19.6K ﹤0.01% 453
2022
Q1 		$88K Buy
1,483
+238
+19% +$15.2K ﹤0.01% 449
2021
Q4 		$90K Buy
1,245
+2
+0.2% +$138 ﹤0.01% 462
2021
Q3 		$86K Sell
1,243
-7
-0.6% -$492 ﹤0.01% 447
2021
Q2 		$86K Sell
1,250
-7
-0.6% -$467 ﹤0.01% 460
2021
Q1 		$81K Sell
1,257
-54
-4% -$3.48K ﹤0.01% 401
2020
Q4 		$76K Buy
1,311
+681
+108% +$41.1K 0.01% 323
2020
Q3 		$40K Sell
630
-321
-34% -$22.3K ﹤0.01% 388
2020
Q2 		$73K Buy
951
+260
+38% +$19.9K 0.01% 311
2020
Q1 		$51.7K Sell
691
-2,110
-75% -$146K 0.01% 341
2019
Q4 		$182K Buy
2,801
+97
+4% +$6.32K 0.02% 234
2019
Q3 		$171K Buy
+2,704
New +$177K 0.02% 280

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Evoke Wealth's GILD Position: Q1 2026 in Review

Evoke Wealth reduced its Gilead Sciences (GILD) stake by 28% in Q1 2026, selling an estimated $156K and leaving 2,909 shares worth $406K. The position accounts for 0.01% of the portfolio, ranked #462.

Evoke Wealth first reported a position in GILD in Q3 2019 and has held it in 17 quarters since. The position peaked at $493K in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Evoke Wealth held 2,909 shares of Gilead Sciences worth $406K as of Q1 2026.
  • Evoke Wealth sold 1,111 Gilead Sciences shares in Q1 2026, an estimated $156K.
  • Gilead Sciences made up 0.01% of Evoke Wealth's portfolio in Q1 2026, its #462 holding.
  • Evoke Wealth first reported a position in Gilead Sciences in Q3 2019 and has held it in 17 quarters since.
  • Evoke Wealth's Gilead Sciences position peaked at $493K in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Evoke Wealth's 13F filing for Q1 2026, filed 15 May 2026.